Literature DB >> 10583854

Activation of an adrenergic and vagally-mediated NANC pathway in surgery-induced fundic relaxation in the rat.

G E Boeckxstaens1, D P Hirsch, A Kodde, T M Moojen, A Blackshaw, G N Tytgat, P J Blommaart.   

Abstract

The aim of this study was to pharmacologically characterize and investigate the possible contribution of adrenergic and nonadrenergic noncholinergic (NANC) pathways involved in the relaxation of the rat gastric fundus following abdominal surgery. Using an intragastric balloon, the effect of skin incision (SI), laparotomy (LT) and manipulation of the small intestine followed by caecal resection (M + R) on fundic pressure was evaluated. SI resulted in a brief relaxation of the gastric fundus abolished by guanethidine and blocked by hexamethonium and the combination of phentolamine, propranolol and atropine (PPA). LT induced a longer lasting relaxation which was abolished by guanethidine and hexamethonium. It was blocked by PPA and the combination of ganglionectomy and vagotomy, but unaffected by atropine, vagotomy or ganglionectomy. M + R induced a long-lasting relaxation which was only partly blocked by guanethidine or PPA, illustrating an inhibitory NANC component. Vagotomy combined with guanethidine completely abolished the relaxation following M + R, whereas it was significantly blocked by hexamethonium and the combination of ganglionectomy with vagotomy. These results indicate that SI, LT and M + R induce inhibition of fundic motility via an adrenergic mechanism. During M + R, an additional vagally mediated inhibitory NANC pathway is activated. Finally, we suggest that LT and M + R inhibit the gastric fundus via both a splanchnic and a vagal reflex pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583854     DOI: 10.1046/j.1365-2982.1999.00172.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  8 in total

Review 1.  Controlling postoperative ileus by vagal activation.

Authors:  Tim Lubbers; Wim Buurman; Misha Luyer
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

2.  The ICAM-1 antisense oligonucleotide ISIS-3082 prevents the development of postoperative ileus in mice.

Authors:  Frans O The; Wouter J de Jonge; Roel J Bennink; Rene M van den Wijngaard; Guy E Boeckxstaens
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

3.  Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats.

Authors:  A Stengel; M Goebel-Stengel; L Wang; A Luckey; E Hu; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2011-05-13       Impact factor: 3.598

4.  Evidence for VIP(1)/PACAP receptors in the afferent pathway mediating surgery-induced fundic relaxation in the rat.

Authors:  G E Boeckxstaens; M Hollmann; S H Heisterkamp; P Robberecht; W J de Jonge; R M van Den Wijngaard; G N Tytgat; P J Blommaart
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

5.  Nitrergic signalling via interstitial cells of Cajal regulates motor activity in murine colon.

Authors:  Barbara Lies; Katharina Beck; Jonas Keppler; Dieter Saur; Dieter Groneberg; Andreas Friebe
Journal:  J Physiol       Date:  2015-08-21       Impact factor: 5.182

6.  Methylnaltrexone in the treatment of opioid-induced constipation.

Authors:  Beverley Greenwood-Van Meerveld; Kelly M Standifer
Journal:  Clin Exp Gastroenterol       Date:  2008-12-14

7.  Electroacupuncture treatment partly promotes the recovery time of postoperative ileus by activating the vagus nerve but not regulating local inflammation.

Authors:  Jun-Fan Fang; Jian-Qiao Fang; Xiao-Mei Shao; Jun-Ying Du; Yi Liang; Wen Wang; Zhe Liu
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

8.  Electroacupuncture at acupoint ST 37(Shangjuxu) improves function of the enteric nervous system in a novel mouse constipation model.

Authors:  Chao Liang; Kaiyue Wang; Bin Xu; Zhi Yu
Journal:  BMC Complement Altern Med       Date:  2016-10-18       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.